INVASIVE INTERVENTIONS IN STRUCTURAL HEART DISEASES: COMPREHENSIVE TECHNIQUES

Invasive Interventions in Structural Heart Diseases-kapak

TRANSCATHETER CLOSURE TECHNIQUES FOR VENTRICULAR SEPTAL DEFECTS: POST-INFARCTION, IATROGENIC, AND CONGENITAL TYPES

Ahmet Yaşar Çizgici

Mehmet Akı̇f Ersoy Thoracı̇c and Cardı̇ovascular Surgery Traı̇nı̇ng and Research Hospital, Department of Cardiology, İstanbul, Türkiye

Çizgici AY. Transcatheter Closure Techniques for Ventricular Septal Defects: Post-Infarction, Iatrogenic, and Congenital Types. In: Tanık VO, Özlek B, editors. Invasive Interventions in Structural Heart Diseases: Comprehensive Techniques. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.463-474.

ABSTRACT

Ventricular Septal Defects (VSD) detected in adults are etiologically named under three main categories: congenital, developing after Myocardial Infraction (post-MI VSD), and iatrogenic and/or post-operative residual VSDs. Device-based transcatheter closure approaches, which started in the late 1980s, are becoming increasingly widespread with the technological development, operator experience and the increase in experienced centers. In this article, we tried to systematically summarize the indications, timing, technical approaches, factors affecting the success of the procedure and procedure-related complications of percutaneous device closure for VSDs detected in adulthood.

Keywords: VSDs type; Transcatheter device closure; Clinical managements

Referanslar

  1. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988;78(2):361-8. [Crossref]  [PubMed]
  2. Chessa M, Carrozza M, Butera G, Negura D, Piazza L, Giamberti A, et al. The impact of interventional cardiology for the management of adults with congenital heart defects. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2006;67(2):258-64. [Crossref]  [PubMed]
  3. Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up. American heart journal. 1999;138(2 Pt 1):339-44. [Crossref]  [PubMed]
  4. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. The Journal of pediatrics. 2008;153(6):807-13. [Crossref]  [PubMed]  [PMC]
  5. Miyake T, Shinohara T, Fukuda T, Ikeoka M, Takemura T. Spontaneous closure of perimembranous ventricular septal defect after school age. Pediatrics international : official journal of the Japan Pediatric Society. 2008;50(5):632-5. [Crossref]  [PubMed]
  6. Turner ME, Bouhout I, Petit CJ, Kalfa D. Transcatheter Closure of Atrial and Ventricular Septal Defects: JACC Focus Seminar. Journal of the American College of Cardiology. 2022;79(22):2247-58. [Crossref]  [PubMed]
  7. Lopez L, Houyel L, Colan SD, Anderson RH, Béland MJ, Aiello VD, et al. Classification of Ventricular Septal Defects for the Eleventh Iteration of the International Classification of Diseases-Striving for Consensus: A Report From the International Society for Nomenclature of Paediatric and Congenital Heart Disease. The Annals of thoracic surgery. 2018;106(5):1578-89. [Crossref]  [PubMed]
  8. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. European heart journal. 2021;42(6):563-645. [PubMed]
  9. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e698-e800. [Crossref]  [PubMed]
  10. Morray BH. Ventricular Septal Defect Closure Devices, Techniques, and Outcomes. Interventional cardiology clinics. 2019;8(1):1-10. [Crossref]  [PubMed]
  11. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 2000;101(1):27-32. [Crossref]  [PubMed]
  12. Faccini A, Butera G. Techniques, Timing, and Prognosis of Transcatheter Post Myocardial Infarction Ventricular Septal Defect Repair. Curr Cardiol Rep. 2019;21(7):59. [Crossref]  [PubMed]
  13. French JK, Hellkamp AS, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, et al. Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). Am J Cardiol. 2010;105(1):59-63. [Crossref]  [PubMed]
  14. Giblett JP, Jenkins DP, Calvert PA. Transcatheter treatment of postinfarct ventricular septal defects. Heart. 2020;106(12):878-84. [Crossref]  [PubMed]
  15. Omar S, Morgan GL, Panchal HB, Thourani V, Rihal CS, Patel R, et al. Management of post-myocardial infarction ventricular septal defects: A critical assessment. J Interv Cardiol. 2018;31(6):939-48. [Crossref]  [PubMed]
  16. Cinq-Mars A, Voisine P, Dagenais F, Charbonneau É, Jacques F, Kalavrouziotis D, et al. Risk factors of mortality after surgical correction of ventricular septal defect following myocardial infarction: Retrospective analysis and review of the literature. Int J Cardiol. 2016;206:27-36. [Crossref]  [PubMed]
  17. Papadopoulos N, Moritz A, Dzemali O, Zierer A, Rouhollapour A, Ackermann H, et al. Long-term results after surgical repair of postinfarction ventricular septal rupture by infarct exclusion technique. The Annals of thoracic surgery. 2009;87(5):1421-5. [Crossref]  [PubMed]
  18. Sabiniewicz R, Huczek Z, Zbroński K, Scisło P, Rymuza B, Kochman J, et al. Percutaneous Closure of Post-Infarction Ventricular Septal Defects-An Over Decade-long Experience. J Interv Cardiol. 2017;30(1):63-71. [Crossref]  [PubMed]
  19. Assenza GE, McElhinney DB, Valente AM, Pearson DD, Volpe M, Martucci G, et al. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interv. 2013;6(1):59-67. [Crossref]  [PubMed]
  20. Schlotter F, de Waha S, Eitel I, Desch S, Fuernau G, Thiele H. Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence. EuroIntervention. 2016;12(1):94-102. [Crossref]  [PubMed]
  21. Barik R. Transcatheter closure of post-myocardial infarction ventricular defect: Where are we? Indian Heart J. 2016;68(1):99-101. [Crossref]  [PubMed]  [PMC]
  22. Ando T, Holmes AA, Taub CC, Slovut DP, DeRose JJ. Iatrogenic Ventricular Septal Defect Following Transcatheter Aortic Valve Replacement: A Systematic Review. Heart Lung Circ. 2016;25(10):968-74. [Crossref]  [PubMed]
  23. Yang L, Tai BC, Khin LW, Quek SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol. 2014;27(3):260-72. [Crossref]  [PubMed]
  24. Koneti NR, Sreeram N, Penumatsa RR, Arramraj SK, Karunakar V, Trieschmann U. Transcatheter retrograde closure of perimembranous ventricular septal defects in children with the Amplatzer duct occluder II device. Journal of the American College of Cardiology. 2012;60(23):2421-2. [Crossref]  [PubMed]
  25. Bacha EA, Cao QL, Starr JP, Waight D, Ebeid MR, Hijazi ZM. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg. 2003;126(6):1718-23. [Crossref]  [PubMed]
  26. Hijazi ZM, Hakim F, Haweleh AA, Madani A, Tarawna W, Hiari A, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2002;56(4):508-15. [Crossref]  [PubMed]
  27. Butera G, Carminati M, Chessa M, Piazza L, Micheletti A, Negura DG, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. Journal of the American College of Cardiology. 2007;50(12):1189-95. [Crossref]  [PubMed]
  28. Tzikas A, Ibrahim R, Velasco-Sanchez D, Freixa X, Alburquenque M, Khairy P, et al. Transcatheter closure of perimembranous ventricular septal defect with the Amplatzer(®) membranous VSD occluder 2: initial world experience and one-year follow-up. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2014;83(4):571-80. [Crossref]  [PubMed]
  29. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. Journal of the American College of Cardiology. 2004;43(7):1257-63. [Crossref]  [PubMed]
  30. Holzer R, Balzer D, Amin Z, Ruiz CE, Feinstein J, Bass J, et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2004;61(2):196-201. [Crossref]  [PubMed]
  31. El-Sisi A, Sobhy R, Jaccoub V, Hamza H. Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II. Pediatr Cardiol. 2017;38(3):596-602. [Crossref]  [PubMed]
  32. Haas NA, Kock L, Bertram H, Boekenkamp R, De Wolf D, Ditkivskyy I, et al. Interventional VSD-Closure with the Nit-Occlud(®) Lê VSD-Coil in 110 Patients: Early and Midterm Results of the EUREVECO-Registry. Pediatr Cardiol. 2017;38(2):215-27. [Crossref]  [PubMed]
  33. Esteves CA, Solarewicz LA, Cassar R, Neves JR, Esteves V, Arrieta R. Occlusion of the perimembranous ventricular septal defect using CERA® devices. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2012;80(2):182-7. [Crossref]  [PubMed]
  34. Shahreyar M, Akinseye O, Nayyar M, Ashraf U, Ibebuogu UN. Post-Myocardial Infarction Ventricular Septal Defect: A Comprehensive Review. Cardiovasc Revasc Med. 2020;21(11):1444-9. [Crossref]  [PubMed]
  35. Rao DS, Barik R, Siva Prasad A. Hemolysis induced by PMIVSD occluder. Indian Heart J. 2016;68 Suppl 2(Suppl 2):S60-s3. [Crossref]  [PubMed]  [PMC]
  36. Kafes H, Ozeke O, Demirkan B, Acar B, Aysenur Ekizler F, Karabulut O, et al. Flail Tricuspid Leaflet During the Percutaneous Closure of Post-Myocardial Infarction Ventricular Septal Defect. CASE (Phila). 2017;1(5):207-9. [Crossref]  [PubMed]  [PMC]